Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Majchrzak-Celińska A"'
Autor:
Majchrzak-Celińska, Aleksandra1 (AUTHOR) majchrzakcelinska@ump.edu.pl, Studzińska-Sroka, Elżbieta2 (AUTHOR) elastudzinska@ump.edu.pl
Publikováno v:
Molecules. Apr2024, Vol. 29 Issue 7, p1682. 21p.
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 80, Iss 2, Pp 207-217 (2023)
Glioblastoma multiforme (GBM), a high-grade astrocytoma, is an incurable brain tumor associated with genetic heterogeneity and dysregulated signaling pathways. As alternations of the endocannabinoid system have been demonstrated in GBM cells, the sub
Externí odkaz:
https://doaj.org/article/2ca2d7f97aea40c296d996c72be8658f
Publikováno v:
Molecules, Vol 29, Iss 7, p 1682 (2024)
Phytocompounds have been evaluated for their anti-glioblastoma actions for decades, with promising results from preclinical studies but only limited translation into clinics. Indeed, by targeting multiple signaling pathways deregulated in cancer, the
Externí odkaz:
https://doaj.org/article/2ca50b9f60274b40856a1b0dcb4d462c
Publikováno v:
Antioxidants, Vol 12, Iss 12, p 2052 (2023)
The development and progression of cancer are associated with the dysregulation of multiple pathways involved in cell proliferation and survival, as well as dysfunction in redox balance, immune response, and inflammation. The master antioxidant pathw
Externí odkaz:
https://doaj.org/article/38d75fad1c044598ac6f2c9526a7942e
Autor:
Joanna Kuźmińska, Agnieszka Sobczak, Aleksandra Majchrzak-Celińska, Izabela Żółnowska, Aleksandra Gostyńska, Barbara Jadach, Violetta Krajka-Kuźniak, Anna Jelińska, Maciej Stawny
Publikováno v:
Pharmaceutics, Vol 15, Iss 8, p 2104 (2023)
Background: Glioblastoma (GBM) is the most frequently occurring primary malignant central nervous system tumor, with a poor prognosis and median survival below two years. Administration of a combination of non-steroidal anti-inflammatory drugs and na
Externí odkaz:
https://doaj.org/article/c9eb5df67286417a98ed42eeebe594c2
Autor:
Majchrzak-Celińska, Aleksandra, Zielińska-Przyjemska, Małgorzata, Wierzchowski, Marcin, Kleszcz, Robert, Studzińska-Sroka, Elżbieta, Kaczmarek, Mariusz, Paluszczak, Jarosław, Cielecka-Piontek, Judyta, Krajka-Kuźniak, Violetta
Publikováno v:
In Advances in Medical Sciences March 2021 66(1):6-20
Autor:
Aleksandra Majchrzak-Celińska, Julia O. Misiorek, Nastassia Kruhlenia, Lukasz Przybyl, Robert Kleszcz, Katarzyna Rolle, Violetta Krajka-Kuźniak
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-18 (2021)
Abstract Background Glioblastoma (GBM) is the deadliest and the most common primary brain tumor in adults. The invasiveness and proliferation of GBM cells can be decreased through the inhibition of Wnt/β-catenin pathway. In this regard, celecoxib is
Externí odkaz:
https://doaj.org/article/a2cc76bcb11e4d9489f8b73501b6fd1f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Farmacja Polska, Vol 76, Iss 1, Pp 10-17 (2020)
Spinal muscular atrophy (SMA) is a neuromuscular disorder that results in the loss of motor neurons. SMA is caused by mutations in the SMN1 gene, leading to the decreased synthesis of the SMN protein, necessary for motor neuron survival. In the past,
Externí odkaz:
https://doaj.org/article/47e154a89cd5495891c8c2c951b7a539
Autor:
Aleksandra Gostyńska, Joanna Czerniel, Joanna Kuźmińska, Jakub Brzozowski, Aleksandra Majchrzak-Celińska, Violetta Krajka-Kuźniak, Maciej Stawny
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 448 (2023)
Background: Glioblastoma (GBM) is an extremely invasive and heterogenous malignant brain tumor. Despite advances in current anticancer therapy, treatment options for glioblastoma remain limited, and tumor recurrence is inevitable. Therefore, alternat
Externí odkaz:
https://doaj.org/article/a73d8c87c74248b19d884ea68ce175e7